Screener
aTyr Pharma ATYR Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001339970-26-000053
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Prepaid expenses and other assets | 109 | 1,445 |
| Accounts payable and accrued expenses | (3,733) | 485 |
| Operating lease liability | (399) | (341) |
| Net cash used in operating activities | (21,868) | (29,314) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (211) | (9) |
| Purchases of available-for-sale investment securities | (13,846) | (41,260) |
| Maturities of available-for-sale investment securities | 40,873 | 40,150 |
Item 1. Financial Statements
FAQ
- What is aTyr Pharma's operating cash flow?
- aTyr Pharma (ATYR) reported operating cash flow of -$9.35M in Q2 2026.
- How has aTyr Pharma's operating cash flow changed year-over-year?
- aTyr Pharma's operating cash flow increased by 32.7% year-over-year, from -$13.89M to -$9.35M.
- What is the long-term trend for aTyr Pharma's operating cash flow?
- Over 4 years (2021 to 2025), aTyr Pharma's operating cash flow has grown at a 17.0% compound annual growth rate (CAGR), from -$33.08M to -$61.99M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about aTyr Pharma's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude